Clinical trial
Prognostic Value of Measures of Central Hypersensitivity in Patients With Low Back Pain
NCT00892411 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Value of Measures of Central Hypersensitivity in Patients With Low Back Pain
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- December 31, 2014
- Enrollment
- 154 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
low back pain, pain measurement